Literature DB >> 31531882

FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.

Marta Milan1,2,3, Chiara Balestrieri1,2, Gabriele Alfarano1,2, Sara Polletti1,2, Elena Prosperini1,2, Paola Spaggiari2, Alessandro Zerbi1,2, Giuseppe R Diaferia3, Gioacchino Natoli1,2.   

Abstract

Differentiation of normal and tumor cells is controlled by regulatory networks enforced by lineage-determining transcription factors (TFs). Among them, TFs such as FOXA1/2 bind naïve chromatin and induce its accessibility, thus establishing new gene regulatory networks. Pancreatic ductal adenocarcinoma (PDAC) is characterized by the coexistence of well- and poorly differentiated cells at all stages of disease. How the transcriptional networks determining such massive cellular heterogeneity are established remains to be determined. We found that FOXA2, a TF controlling pancreas specification, broadly contributed to the cis-regulatory networks of PDACs. Despite being expressed in both well- and poorly differentiated PDAC cells, FOXA2 displayed extensively different genomic distributions and controlled distinct gene expression programs. Grade-specific functions of FOXA2 depended on its partnership with TFs whose expression varied depending on the differentiation grade. These data suggest that FOXA2 contributes to the regulatory networks of heterogeneous PDAC cells via interactions with alternative partner TFs.
© 2019 The Authors.

Entities:  

Keywords:  FOXA2; differentiation; pancreatic cancer; transcription

Year:  2019        PMID: 31531882      PMCID: PMC6792020          DOI: 10.15252/embj.2019102161

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  Hox gene function in vertebrate gut morphogenesis: the case of the caecum.

Authors:  Giovanna Zacchetti; Denis Duboule; Jozsef Zakany
Journal:  Development       Date:  2007-10-17       Impact factor: 6.868

2.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

3.  Full-length RNA-seq from single cells using Smart-seq2.

Authors:  Simone Picelli; Omid R Faridani; Asa K Björklund; Gösta Winberg; Sven Sagasser; Rickard Sandberg
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

4.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

5.  Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Yan Song; M Kay Washington; Howard C Crawford
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

6.  Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis.

Authors:  Huajing Wan; Sharon Dingle; Yan Xu; Valérie Besnard; Klaus H Kaestner; Siew-Lan Ang; Susan Wert; Mildred T Stahlman; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

7.  Tracking the Evolution of Non-Small-Cell Lung Cancer.

Authors:  Mariam Jamal-Hanjani; Gareth A Wilson; Nicholas McGranahan; Nicolai J Birkbak; Thomas B K Watkins; Selvaraju Veeriah; Seema Shafi; Diana H Johnson; Richard Mitter; Rachel Rosenthal; Max Salm; Stuart Horswell; Mickael Escudero; Nik Matthews; Andrew Rowan; Tim Chambers; David A Moore; Samra Turajlic; Hang Xu; Siow-Ming Lee; Martin D Forster; Tanya Ahmad; Crispin T Hiley; Christopher Abbosh; Mary Falzon; Elaine Borg; Teresa Marafioti; David Lawrence; Martin Hayward; Shyam Kolvekar; Nikolaos Panagiotopoulos; Sam M Janes; Ricky Thakrar; Asia Ahmed; Fiona Blackhall; Yvonne Summers; Rajesh Shah; Leena Joseph; Anne M Quinn; Phil A Crosbie; Babu Naidu; Gary Middleton; Gerald Langman; Simon Trotter; Marianne Nicolson; Hardy Remmen; Keith Kerr; Mahendran Chetty; Lesley Gomersall; Dean A Fennell; Apostolos Nakas; Sridhar Rathinam; Girija Anand; Sajid Khan; Peter Russell; Veni Ezhil; Babikir Ismail; Melanie Irvin-Sellers; Vineet Prakash; Jason F Lester; Malgorzata Kornaszewska; Richard Attanoos; Haydn Adams; Helen Davies; Stefan Dentro; Philippe Taniere; Brendan O'Sullivan; Helen L Lowe; John A Hartley; Natasha Iles; Harriet Bell; Yenting Ngai; Jacqui A Shaw; Javier Herrero; Zoltan Szallasi; Roland F Schwarz; Aengus Stewart; Sergio A Quezada; John Le Quesne; Peter Van Loo; Caroline Dive; Allan Hackshaw; Charles Swanton
Journal:  N Engl J Med       Date:  2017-04-26       Impact factor: 91.245

8.  Inferring direct DNA binding from ChIP-seq.

Authors:  Timothy L Bailey; Philip Machanick
Journal:  Nucleic Acids Res       Date:  2012-05-18       Impact factor: 16.971

9.  Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Andrew E Teschendorff; Kelly A Holmes; H Raza Ali; Mark J Dunning; Gordon D Brown; Ondrej Gojis; Ian O Ellis; Andrew R Green; Simak Ali; Suet-Feung Chin; Carlo Palmieri; Carlos Caldas; Jason S Carroll
Journal:  Nature       Date:  2012-01-04       Impact factor: 49.962

10.  High constitutive activity of a broad panel of housekeeping and tissue-specific cis-regulatory elements depends on a subset of ETS proteins.

Authors:  Alessia Curina; Alberto Termanini; Iros Barozzi; Elena Prosperini; Marta Simonatto; Sara Polletti; Alessio Silvola; Monica Soldi; Liv Austenaa; Tiziana Bonaldi; Serena Ghisletti; Gioacchino Natoli
Journal:  Genes Dev       Date:  2017-03-08       Impact factor: 11.361

View more
  9 in total

1.  TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer.

Authors:  Mengyu Tu; Lukas Klein; Elisa Espinet; Theodoros Georgomanolis; Florian Wegwitz; Xiaojuan Li; Laura Urbach; Adi Danieli-Mackay; Stefan Küffer; Kamil Bojarczuk; Athanasia Mizi; Ufuk Günesdogan; Björn Chapuy; Zuguang Gu; Albrecht Neesse; Uday Kishore; Philipp Ströbel; Elisabeth Hessmann; Stephan A Hahn; Andreas Trumpp; Argyris Papantonis; Volker Ellenrieder; Shiv K Singh
Journal:  Nat Cancer       Date:  2021-11-15

2.  Extended lymphadenectomy benefits patients with borderline resectable pancreatic head cancer-a single-center retrospective study.

Authors:  Jing Wang; Shao-Cheng Lyu; Ji-Qiao Zhu; Xian-Liang Li; Ren Lang; Qiang He
Journal:  Gland Surg       Date:  2021-10

Review 3.  Pioneer factors as master regulators of the epigenome and cell fate.

Authors:  Aurelio Balsalobre; Jacques Drouin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-03-09       Impact factor: 113.915

4.  Blocking the road to de-differentiation: HNF1A/KDM6A complex safeguards epithelial integrity in pancreatic cancer.

Authors:  Stefanie Bärthel; Günter Schneider; Dieter Saur
Journal:  EMBO J       Date:  2020-04-01       Impact factor: 11.598

Review 5.  Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants.

Authors:  Marta Milan; Giuseppe R Diaferia; Gioacchino Natoli
Journal:  EMBO J       Date:  2021-04-12       Impact factor: 14.012

Review 6.  Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.

Authors:  Nikita Aggarwal; Joni Yadav; Kulbhushan Thakur; Rakhi Bibban; Arun Chhokar; Tanya Tripathi; Anjali Bhat; Tejveer Singh; Mohit Jadli; Ujala Singh; Manoj K Kashyap; Alok C Bharti
Journal:  Front Cell Infect Microbiol       Date:  2020-12-02       Impact factor: 5.293

7.  SOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner.

Authors:  Eugene Kopantzev; Liya Kondratyeva; Marina Kopantseva; Kirill Kashkin; Dmitry Gnatenko; Elizaveta Grigorieva; Irina Alekseenko; Dina Safina; Igor Chernov
Journal:  Biomedicines       Date:  2022-06-21

8.  Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer.

Authors:  Niklas Krebs; Lukas Klein; Florian Wegwitz; Elisa Espinet; Hans Carlo Maurer; Mengyu Tu; Frederike Penz; Stefan Küffer; Xingbo Xu; Hanibal Bohnenberger; Silke Cameron; Marius Brunner; Albrecht Neesse; Uday Kishore; Elisabeth Hessmann; Andreas Trumpp; Philipp Ströbel; Rolf A Brekken; Volker Ellenrieder; Shiv K Singh
Journal:  JCI Insight       Date:  2022-08-22

9.  EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer.

Authors:  Hwa-Ryeon Kim; Juhye Yim; Hye-Been Yoo; Seung Eon Lee; Sumin Oh; Sungju Jung; Chang-Il Hwang; Dong-Myung Shin; TaeSoo Kim; Kyung Hyun Yoo; You-Sun Kim; Han-Woong Lee; Jae-Seok Roe
Journal:  NAR Cancer       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.